1. Home
  2. SLNO vs ENS Comparison

SLNO vs ENS Comparison

Compare SLNO & ENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • ENS
  • Stock Information
  • Founded
  • SLNO 1999
  • ENS 1991
  • Country
  • SLNO United States
  • ENS United States
  • Employees
  • SLNO N/A
  • ENS N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ENS Industrial Machinery/Components
  • Sector
  • SLNO Health Care
  • ENS Technology
  • Exchange
  • SLNO Nasdaq
  • ENS Nasdaq
  • Market Cap
  • SLNO 3.8B
  • ENS 3.4B
  • IPO Year
  • SLNO 2014
  • ENS N/A
  • Fundamental
  • Price
  • SLNO $68.57
  • ENS $102.03
  • Analyst Decision
  • SLNO Strong Buy
  • ENS Strong Buy
  • Analyst Count
  • SLNO 10
  • ENS 2
  • Target Price
  • SLNO $112.50
  • ENS $117.50
  • AVG Volume (30 Days)
  • SLNO 1.6M
  • ENS 350.6K
  • Earning Date
  • SLNO 08-06-2025
  • ENS 08-06-2025
  • Dividend Yield
  • SLNO N/A
  • ENS 0.94%
  • EPS Growth
  • SLNO N/A
  • ENS 32.64
  • EPS
  • SLNO N/A
  • ENS 8.77
  • Revenue
  • SLNO $32,656,999.00
  • ENS $3,657,687,000.00
  • Revenue This Year
  • SLNO N/A
  • ENS $2.47
  • Revenue Next Year
  • SLNO $209.31
  • ENS $3.32
  • P/E Ratio
  • SLNO N/A
  • ENS $11.64
  • Revenue Growth
  • SLNO N/A
  • ENS 3.73
  • 52 Week Low
  • SLNO $41.50
  • ENS $76.57
  • 52 Week High
  • SLNO $90.32
  • ENS $104.36
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 32.58
  • ENS 68.09
  • Support Level
  • SLNO $66.72
  • ENS $97.03
  • Resistance Level
  • SLNO $87.17
  • ENS $100.86
  • Average True Range (ATR)
  • SLNO 3.81
  • ENS 2.16
  • MACD
  • SLNO -1.52
  • ENS 0.29
  • Stochastic Oscillator
  • SLNO 21.55
  • ENS 97.36

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.

Share on Social Networks: